Senate Bill No. by Senator Talbot and Representative Chassion amends R.S. 22:1028.5 to enhance coverage for biomarker testing. The bill specifically ensures that health coverage plans provide biomarker testing without disruptions in care, such as the need for multiple biopsies. It introduces new provisions stating that coverage for biomarker tests cannot be conditioned on laboratory classifications or credentialing standards that are unrelated to the performance of the tests.

Additionally, the bill enacts a new subsection (F) that clarifies that in the event of a conflict between this section and R.S. 22:1028.3, the provisions of this bill will take precedence. The act is set to become effective upon the governor's signature or after the designated time for bills to become law without a signature, as outlined in the Louisiana Constitution.

Statutes affected:
SB169 Original: 22:5(D)
SB169 Engrossed: 22:5(D)
SB169 Enrolled: 22:5(D)